Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Rentschler Biopharma Plans for the Construction of a New State-of-the-Art Buffer Media Station in Germany
Rentschler Biopharma is set to build a new stateoftheart buffer media station in Laupheim, Germany
Merck Invests US$74.9 million (€70 million) to Expand Manufacturing Capacity in Missouri, USA
Merck is investing $749 million 70 million to enhance its ADC manufacturing capabilities and capacity at its bioconjugation center of excellence in St Louis, Missouri, USA
SK pharmteco Invests US$260 million to Expand Peptide Production in South Korea
SK pharmteco invests US$260 million to expand its small molecule and peptide production capabilities in South Korea A new fivestory, 136,000 squarefoot multipurpose building is being developed to enhance capacity and capabilities
Eurofins Genomics Plans for the Expasnion of Manufacturing Facility in USA
Eurofins Genomics is set to expand its capabilities with the addition of a new GMP oligonucleotide manufacturing facility in the USA The expanded 75,000 square feet facility significantly boosts manufacturing capacity
eXmoor Pharma Plans for the Construction of New Manufacturing Facility in UK
EXmoor Pharma plans for the construction of new GMP cell and gene therapy manufacturing facility in UK The newly constructed facility, designed inhouse as a flexible and scalable manufacturing hub, features integrated process development and analytical labs
Vetter Opens New State-of-the-Art Clinical Production Site in Austria
Vetter palns to open new new stateoftheart clinical production site in AustriaThe new floor will offer additional office space, featuring individual workstations, clusterstyle offices, and meeting rooms In response to the current growth, this investment is made in the Rankweil site
ESTEVE Invests US$108 mn (€100 mn) to Construct New Plant in Spain
ESTEVE plans to invest US$108 mn 100 mn to construct new plant in its industrial centre in celr girona, Spain The new facility will expand its production capacity for active pharmaceutical ingredients at its primary industrial centre
Kadans Science Partner Plans to Construct New Lab Facility in Massachusetts, USA
Kadans Science Partner plans for the construction of new purposebuilt wet lab facilities at Massachusetts, USA The 139,000 square feet development will feature six storeys of cuttingedge lab and office space, designed with full flexibility to accommodate either single or multiple tenants
Grünenthal Invests US$88 million (€80 million) to Open Production Site in Latin America
Grnenthal invests US$88 million 80 million in its Latin American production facilities to enhance the reliability of medicine supply for patients The 50,000squaremeter campus is Ecuadors largest and most advanced pharmaceutical
INCOG BioPharma Expands its Manufacturing Facilities in USA
INCOG BioPharma Services plans to expand its second building, enhanced manufacturing capabilities in USA The expansion includes the construction of a second 100,000squarefoot facility on its campus, scheduled to break ground in August
